alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
## Breadcrumb

-  Publications 
-  Articles 

#           Investigation of uptake and retention of atmospheric Hg(II) by boreal forest plants using stable Hg isotopes      

      January 1, 2009    

Although there is now a general consensus among mercury (Hg) biogeochemists that increased atmospheric inputs of inorganic Hg(II) to lakes and watersheds can result in increased methylmercury (MeHg) concentrations in fish, researchers still lack kinetic data describing the movement of Hg from the atmosphere, through watershed and lake ecosystems, and into fish. The use of isotopically enriched Hg species in environmental studies now allows experimentally applied new Hg to be distinguished from ambient Hg naturally present in the system. Four different enriched stable Hg(II) isotope “spikes” were applied sequentially over four years to the ground vegetation of a microcatchment at the Experimental Lakes Area (ELA) in the remote boreal forest of Canada to examine retention of Hg(II) following deposition. Areal masses of the spikes and ambient THg (all forms of Hg in a sample) were monitored for eight years, and the pattern of spike retention was used to estimate retention of newly deposited ambient Hg within the ground vegetation pool. Fifty to eighty percent of applied spike Hg was initially retained by ground vegetation. The areal mass of spike Hg declined exponentially over time and was best described by a first-order process with constants (k) ranging between 9.7 × 10−4 day−1 and 11.6 × 10−4day−1. Average half-life (t1/2) of spike Hg within the ground vegetation pool (±S.D.) was 704 ± 52 days. This retention of new atmospheric Hg(II) by vegetation delays movement of new Hg(II) into soil, runoff, and finally into adjacent lakes. Ground-applied Hg(II) spikes were not detected in tree foliage and litterfall, indicating that stomatal and/or root uptake of previously deposited Hg (i.e., “recycled” from ground vegetation or soil Hg pools) were likely not large sources of foliar Hg under these experimental conditions.

## Citation Information

## Related Content

                  -              Connect           

#### David P Krabbenhoft

##### Scientist Emeritus

Mercury Research Laboratory

Mercury Research Laboratory

dpkrabbe@usgs.gov

608-335-4234

## Related Content

#### David P Krabbenhoft

##### Scientist Emeritus

Mercury Research Laboratory

Mercury Research Laboratory

dpkrabbe@usgs.gov

608-335-4234

### Contact

####               Ecosystems Mission Area Headquarters          

12201 Sunrise Valley DrReston, VA20192United States

### Explore Search

                  - Biology
                  - Water
                  - Mercury

View All **
Exhibit 99.4

               Statement Under Oath of Principal Financial Officer
       Regarding Facts and Circumstances Relating to Exchange Act Filings

I, Dennis M. O'Connor, state and attest that:

     (1)  To the  best of my  knowledge,  based  upon a  review  of the  covered
          reports  of  M.B.A.  Holdings,  Inc.,  and,  except  as  corrected  or
          supplemented in a subsequent covered report:

          o    no covered  report  contained  an untrue  statement of a material
               fact as of the end of the period  covered  by such  report (or in
               the case of a report on Form 8-K or definitive  proxy  materials,
               as of the date on which it was filed); and

          o    no covered  report  omitted to state a material fact necessary to
               make  the  statements  in the  covered  report,  in  light of the
               circumstances  under which they were made,  not  misleading as of
               the end of the period covered by such report (or in the case of a
               report on Form 8-K or definitive proxy materials,  as of the date
               on which it was filed).

     (2)  I have  reviewed the  contents of this  statement  with the  Company's
          Audit Committee.

     (3)  In this statement  under oath,  each of the following,  if filed on or
          before the date of this statement, is a "covered report":

          o    Annual Report on Form 10-K of M.B.A. Holdings,  Inc. for the year
               ended  October 31, 2001 filed with the  Securities  and  Exchange
               Commission, File Number 1-9183,

          o    all  reports  on Form  10-Q,  all  reports  on  Form  8-K and all
               definitive  proxy materials of M.B.A.  Holdings,  Inc. filed with
               the  Commission  subsequent  to  the  filing  of  the  Form  10-K
               identified above; and

          o    any amendments to any of the foregoing.

By: /s/ Dennis M. O'Connor
-------------------------------
Dennis M. O'Connor
June 14, 2004

                                              Subscribed and sworn to before me
                                              This 14th day of June 2004.

                                              /s/ Marjorie Smith
                                              ----------------------------------
                                              Notary Public
                                              My Commission Expires:
                                              March 18, 2008



                                       19
EX-10.06



 Exhibit 10.6 
 Compensation of Directors. 
 Effective July 1, 2012,
each Director, other than the Michael S. Maurer, the Chairman of the Board, and Morris L. Maurer, the President and Chief Executive Officer, will receive shares of stock in July of each year worth approximately $15,000 and will be paid $833 per
board meeting attended. 
 The chair of the Audit Committee will receive a cash retainer of $3,000 in July of each year. All
other committee chairs will receive a cash payment of $1,000 payable in July of each year. 
 In addition, for all committee
meetings other than those of the Audit Committee, Directors are paid $500 per committee meeting attended. Members of the Audit Committee receive $700 per Audit Committee meeting attended. 

Michael S. Maurer, who is the Chairman of the Board of Directors but is not an employee or an executive officer, will receive an annual
director fee composed of a cash payment equal to $40,000 in January and will receive a grant of shares of the Company equal to $60,000 in July. Mr. Maurer receives no other fees in his capacity as a Director. 

Morris L. Maurer is not separately compensated for his services as director of the Company or the Bank.
##### 



PHARMANET DEVELOPMENT GROUP, INC.
RESTRICTED STOCK UNIT ISSUANCE AGREEMENT
 RECITALS
    NOW, THEREFORE
 Grant of Restricted Stock Units
 AWARD SUMMARY
 Award Date:
    
    ***Number of Shares Subject to
Award:
    
    *** shares of Common Stock (the Shares)Vesting Schedule:
    
    The Participant shall vest with respect to one-sixth of
the Shares on June 30 and December 31 and of each year
commencing December 31, 2006, provided the Participant
remains in continuous employment through each such date.
The Shares may vest on an accelerated basis prior to
these vesting dates in accordance with the provisions of
Paragraph 4 of this Agreement. In no event shall any
Shares vest after the date of the Participants
termination of employment.




---



##### 



Issuance Dates
    
    Each Share in which the Participant vests in accordance
with the foregoing Vesting Schedule shall be issued on the
date (the Issue Date) on which that Share so vests or as
soon thereafter as administratively practicable, but in
no event later than the close of the calendar year in which
such Issue Date occurs or (if later) the fifteenth (15th)
day of the third calendar month following such Issue Date.
The issuance of the Shares shall be subject to the
Companys collection of any applicable Withholding Taxes in
accordance the procedures set forth in Paragraph 6 of this
Agreement.
 Limited Transferability
 Cessation of Service as a Board Member
 Change in Control
   2




---



##### 



Adjustment in Shares
 Issuance of Shares of Common Stock
  provided, however
 3




---



##### 



Compliance with Laws and Regulations
   Successors and Assigns
 Notices
 Construction
 4




---



##### 



Governing Law
 No Impairment of Rights
 Data Privacy.
   5




---



##### 



IN WITNESS WHEREOF
 PHARMANET DEVELOPMENT GROUP, INC.Signature:Name:
    
    Jeffrey P. McMullenTitle:
    
    President and Chief Executive OfficerPARTICIPANTSignature:Name:Address:
 6




---



##### 



APPENDIX A  DEFINITIONS
  Agreement
 Award
 Award Date
 Board
 Change in Control
    Code
 Committee
 Common Stock
 A-1




---



##### 



Company
 Exchange Act
 Fair Market Value
     Plan
 Participant
 Stock Exchange
 Related Corporation
 A-2




---



##### 



Withholding Taxes
 A-3
Docket No. FAA-2011-1090
**Exhibit 31.1**

 

**CERTIFICATION OF**

**CHIEF EXECUTIVE OFFICER**

**TIPPINGPOINT TECHNOLOGIES, INC.**

 

I, Kip McClanahan, certify that: 

 

1. I have reviewed this quarterly report on Form 10-Q of TippingPoint Technologies, Inc.; 

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; 

 

3. Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; 

 

4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensurethat material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; 

 

(b) evaluated the effectiveness of the registrant’s disclosure controlsand procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report, based on such evaluation; and 

 

(c) disclosed in this quarterly report any change in the registrant’sinternal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financialreporting; and 

 

5. The registrant’s other certifyingofficer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing theequivalent function): 

 

(a) all significant deficiencies andmaterial weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

(b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: August 31, 2004
## Breadcrumb

-  Publications 
-  Reports 

#           Tsunami hazards— A national threat      

      February 10, 2006    

In December 2004, when a tsunami killed more than 200,000 people in 11 countries around the Indian Ocean, the United States was reminded of its own tsunami risks.

In fact, devastating tsunamis have struck North America before and are sure to strike again. Especially vulnerable are the five Pacific States--Hawaii, Alaska, Washington, Oregon, and California--and the U.S. Caribbean islands.

In the wake of the Indian Ocean disaster, the United States is redoubling its efforts to assess the Nation's tsunami hazards, provide tsunami education, and improve its system for tsunami warning.

The U.S. Geological Survey (USGS) is helping to meet these needs, in partnership with the National Oceanic and Atmospheric Administration (NOAA) and with coastal States and counties.

## Citation Information

### Study Area

### Explore Search

                  - United States

View All **
```
[Federal Register Volume 61, Number 153 (Wednesday, August 7, 1996)]
[Corrections]
[Pages 41208-41209]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X96-50807]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

Revised Non-Foreign Overseas Per Diem Rates

Correction

    In notice document 96-16213 beginning on page 33097 in the issue of 
Wednesday, June 26, 1996, make the following correction:
    On page 33099, the table is replaced with the following:

BILLING CODE 1505-01-D

[[Page 41209]]

[GRAPHIC] [TIFF OMITTED] TN07AU96.000

BILLING CODE 1505-01-C
```
David TIMMONS, Appellant, v. STATE of Florida, Appellee.

No. 4D18-371

District Court of Appeal of Florida, Fourth District.

[June 28, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
```

[Federal Register Volume 60, Number 16 (Wednesday, January 25, 1995)]
[Notices]
[Page 4903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X95-30125]

-----------------------------------------------------------------------
```
Walter MAINO Jr., Appellant(s)/Petitioner(s), v. BENWORTH CAPITAL PARTNERS, LLC, Appellee(s)/Respondent(s),

CASE NO.: 3D18-0316

District Court of Appeal of Florida, Third District.

FEBRUARY 22, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
**EXHIBIT
      23.1**





**CONSENT
      OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**





We
      consent to the incorporation by reference in Registration Statements on Form
      S-3
      (No. 333-109451), Form S-3, as amended (No. 333-127462), Form S-8 (No.
      333-140084), Form S-8 (No. 333-140086), Form S-8, as amended (No. 333-129164)
      and Form S-3, as amended (No. 333-131191) of New Dragon Asia Corp. of our report
      dated March 11, 2008, relating to our audits of the consolidated financial
      statements, which appear in this Annual Report on Form 10-K of New Dragon Asia
      Corp. for the year ended December 25, 2007.





**/s/
      GROBSTEIN, HORWATH & COMPANY LLP**





Sherman
      Oaks, California


March
      14,
      2008
This section of the FEDERAL REGISTER

contains editorial corrections of previously

published Presidential, Rule, Proposed Rule,

and Notice documents. These corrections are

prepared by the Office of the Federal

Register. Agency prepared corrections are

issued as signed documents and appear in

the appropriate document categories

elsewhere in the issue.

Corrections Federal Register

25016

Vol. 61, No. 97

Friday, May 17, 1996

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

[ID-933-1430-01; IDI-31741]

Notice of Public Meetings for Proposed

Land Withdrawal: Idaho

Correction

In notice document 96–10652

beginning on page 19083 in the issue of

Tuesday, April 30, 1996, make the

following corrections:

1. On page 19084, in the first column,

in the land description under

‘‘(Emitters)’’, in T. 9 S., R. 6 E., in Sec.

15, ‘‘NW1⁄2’’ should read ‘‘NW1⁄4’’.

2. On the same page, in the same

column, in the land description under

‘‘(Emitters)’’, in T. 13 S., R. 9 E., in Sec.

10, ‘‘NE1⁄2’’ should read ‘‘NE1⁄4’’.

BILLING CODE 1505–01–D

NUCLEAR REGULATORY

COMMISSION

Atomic Safety and Licensing Board

[Docket No. 50–160–Ren; ASLBP No. 95–

704–01–Ren]

Georgia Institute of Technology,

Atlanta, Georgia; Georgia Tech

Research Reactor; (Renewal of Facility

License No. R–97)

Correction

In notice document 96–11045,

beginning on page 19961, in the issue of

Friday, May 3, 1996, make the following

corrections:

1. On page 19961, in the third

column, in the third full paragraph, in

the ninth line, ‘‘is’’should read ‘‘if’’.

2. On the same page, in the same

column, in the fourth full paragraph, in

the second line, ‘‘10 CFR 2.75(a)’’

should read ‘‘10 CFR 2.715(a)’’.

BILLING CODE 1505–01–D
Exh 10.10 -- Named Executive Officer Compensation




Exhibit 10.10


Summary of 2012 Named Executive Officer Cash Compensation


The Compensation Committee of our Board of Directors has approved 2012 base salaries for our named executive officers in amounts unchanged from 2011, as set forth below.


The Compensation Committee has also approved a process for the determination of 2012 cash bonuses for our named executive officers, pursuant to which bonuses, if any, will be determined in the discretion of the Compensation Committee based on the achievement of certain corporate goals and individual performance in 2012.  The corporate goals include objectives relating to the development of existing drug candidates, the identification of additional drug candidates and the achievement of certain financial and business goals.  Achievement of these corporate goals will be evaluated by the Compensation Committee in making determinations regarding bonuses for 2012 performance.  However, the Compensation Committee retains broad discretion over the amount and payment of cash bonuses and is not bound by any pre-determined agreement, formula or other standard with respect to such decisions.


The Compensation Committee has established a bonus target, expressed as a percentage of base salary, for each of our named executive officers, assuming full achievement of corporate goals and a high level of individual performance.  The bonus target percentages for each of our named executive officers are unchanged from 2011, as set forth below.


	
						
	Name and Position
	 
	2012
Base Salary
	2012
Bonus Target

	Arthur T. Sands, M.D., Ph.D.
President and Chief Executive Officer
	 
	$
	580,000
	

	50%

	 
	 
	 
	 

	Alan J. Main, Ph.D.
Executive Vice President of Pharmaceutical Research
	 
	$
	350,000
	

	35%

	 
	 
	 
	 

	Jeffrey L. Wade, J.D.
Executive Vice President, Corporate Development and Chief Financial Officer
	 
	$
	385,000
	

	40%

	 
	 
	 
	 

	Brian P. Zambrowicz, Ph.D.
Executive Vice President and Chief Scientific Officer
	 
	$
	400,000
	

	40%

	 
	 
	 
	 

	Pablo Lapuerta, M.D.
Senior Vice President, Clinical Development and Chief Medical Officer
	 
	$
	345,000
	

	30%
Exhibit 31.2

CERTIFICATE OF THE CHIEF FINANCIAL OFFICER

I, the Chief Financial Officer, of Witness Systems, Inc. (the "registrant"), certify that:

1.     I
have reviewed this report on Form 10-Q of the registrant;

2.     Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



5.     The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors:



Dated
this 13th day of November 2003.

| |  | /s/WILLIAM F. EVANSWilliam F. Evans
Chief Financial Officer
| |  | -----------------------------------------------------------

43

---

QuickLinks
[Federal Register Volume 61, Number 192 (Wednesday, October 2, 1996)]
[Corrections]
[Page 51495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X96-21002]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Research and Special Program Administration

49 CFR Part 173

[Docket No. HM-181H; Amdt. Nos. 171-147, 172-150, 173-255, 178-177]
RIN 2137-AC66


Performance-Oriented Packaging Standards; Final Transitional 
Provisions

Correction

    In rule document 96-24398 beginning on page 50616 in the issue of 
Thursday, September 26, 1996, make the following corrections:


Sec. 173.28  [Corrected]

    On page 50625, in the first column, in Sec. 173.28(b)(4)(ii), the 
formulas should read as follows:

Formula for Metric Units
[GRAPHIC] [TIFF OMITTED] TP26JN96.000

Formula for U.S. Standard Units
[GRAPHIC] [TIFF OMITTED] TP26JN96.001

BILLING CODE 1505-01-D
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-START>                             SEP-01-1999
<PERIOD-END>                               MAY-31-2000
<CASH>                                         161,770
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                    182,389
<CURRENT-ASSETS>                             3,063,974
<PP&E>                                         179,181
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               3,249,208
<CURRENT-LIABILITIES>                          115,847
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         8,805
<OTHER-SE>                                   3,124,556
<TOTAL-LIABILITY-AND-EQUITY>                 3,249,208
<SALES>                                         19,306
<TOTAL-REVENUES>                                19,306
<CGS>                                          137,153
<TOTAL-COSTS>                                1,598,557
<OTHER-EXPENSES>                             (111,732)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,604,672)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,393,632)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,393,632)
<EPS-BASIC>                                     (0.34)
<EPS-DILUTED>                                   (0.34)


</TABLE>